智通财经APP获悉，天星医疗(01609)午后涨超7%，截至发稿，涨7.07%，报149.9港元，成交额3001.51万港元。
消息面上，天星医疗宣布，已获恒生指数有限公司选定并将被纳入恒生综合指数成份股，自9月7日起生效。被纳入恒生综合指数成份股后，公司股份预计将符合沪港通及深港通交易的纳入标准。入通有望进一步提升公司关注度和可投资性，扩大潜在投资者覆盖。
根据天星医疗中报显示，上半年公司收入约人民币1.63亿元，同比增长21.6%；经调整后的净利润约4889.7万元，同比增长24.3%。期内来源于海外的销售收入约为4069.8万元，较2025年同期增长70.6%。海外收入占总收入的比例提升至24.9%。公司同时宣布，拟回购不超过290万股H股，占公司已发行H股总数约5.29%。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.